Antiphospholipid syndrome (APS) is a hypercoagulable state characterized by vascular
thromboses, pregnancy morbidity and the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia. It is
characterized by the presence of antiphospholipid antibodies (APL) that are directed against …

Antiphospholipid syndrome (APS) is one of the most common non-inherited causes of
thrombophilia. It is estimated to affect up to 1 in 100 people. APS is an autoimmune disease …

The antiphospholipid syndrome (APS) is characterised by a great clinical variability, with
diverse clinical presentations such as venous thromboembolism, preeclampsia, arterial …

Antiphospholipid syndrome (APs) is an autoimmune systemic disease characterized by
vascular thrombosis (arterial or venous) and/or pregnancy complications associated with the …

The antiphospholipid syndrome (APS) was defined 20 years ago by Hughes as a
thrombosis (arterial and/or venous) state and/or recurrent pregnancy loss in the presence of …

Antiphospholipid syndrome is being increasingly recognized as a disease with a myriad of
clinical manifestations ranging from recurrent thrombosis and pregnancy morbidity to …

Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting
as recurrent thrombotic events and pregnancy morbidity, in association with positive …

Antiphospholipid syndrome [APS] is an acquired thrombophilia which is associated with
morbidity and mortality from thrombosis and pregnancy failure. It is important to recognise …

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …